These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24781537)

  • 1. Zinc-finger nucleases make the cut in HIV.
    Owens B
    Nat Rev Drug Discov; 2014 May; 13(5):321-2. PubMed ID: 24781537
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption or Excision of Provirus as an Approach to HIV Cure.
    Jerome KR
    AIDS Patient Care STDS; 2016 Dec; 30(12):551-555. PubMed ID: 27855263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
    Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM
    Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.
    Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; DiGiusto DL
    Mol Ther; 2013 Jun; 21(6):1259-69. PubMed ID: 23587921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly.
    Kim HJ; Lee HJ; Kim H; Cho SW; Kim JS
    Genome Res; 2009 Jul; 19(7):1279-88. PubMed ID: 19470664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and biomedical applications of engineered nucleases.
    Pan Y; Xiao L; Li AS; Zhang X; Sirois P; Zhang J; Li K
    Mol Biotechnol; 2013 Sep; 55(1):54-62. PubMed ID: 23089945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-FokI-based zinc finger nucleases.
    Imanishi M; Negi S; Sugiura Y
    Methods Mol Biol; 2010; 649():337-49. PubMed ID: 20680845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on the CRISPR Gene-edited babies' case.
    Cong Y
    Indian J Med Ethics; 2019; 4 (NS)(4):297-300. PubMed ID: 31791938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure based design of protein linkers for zinc finger nuclease.
    Anand P; Schug A; Wenzel W
    FEBS Lett; 2013 Oct; 587(19):3231-5. PubMed ID: 23994524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic editing opens new avenues for zebrafish as a model for neurodegeneration.
    Schmid B; Haass C
    J Neurochem; 2013 Nov; 127(4):461-70. PubMed ID: 24117801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial Strategies for Long-term Control of HIV Infection.
    Kwon D; Han MJ; Seo KW; Kang KS
    AIDS Rev; 2020 Dec; 22(4):175-182. PubMed ID: 33401284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted gene editing enters clinic.
    Ledford H
    Nature; 2011 Mar; 471(7336):16. PubMed ID: 21368795
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro assessment of zinc finger nuclease activity.
    Cathomen T; Söllü C
    Methods Mol Biol; 2010; 649():227-35. PubMed ID: 20680837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV: CRISPR screen identifies novel therapeutic targets.
    Crunkhorn S
    Nat Rev Drug Discov; 2017 Feb; 16(2):88. PubMed ID: 28148946
    [No Abstract]   [Full Text] [Related]  

  • 16. Zinc-finger nucleases meet iPS cells: Zinc positive: tailored genome engineering meets reprogramming.
    Cathomen T; Schambach A
    Gene Ther; 2010 Jan; 17(1):1-3. PubMed ID: 19907499
    [No Abstract]   [Full Text] [Related]  

  • 17. Zinc-finger nucleases for somatic gene therapy: the next frontier.
    Rahman SH; Maeder ML; Joung JK; Cathomen T
    Hum Gene Ther; 2011 Aug; 22(8):925-33. PubMed ID: 21631241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell derived liposomes expressing CCR5 as a new targeted drug-delivery system for HIV infected cells.
    Bronshtein T; Toledano N; Danino D; Pollack S; Machluf M
    J Control Release; 2011 Apr; 151(2):139-48. PubMed ID: 21362450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc-finger nucleases transition to the CoDA.
    Segal DJ
    Nat Methods; 2011 Jan; 8(1):53-5. PubMed ID: 21191373
    [No Abstract]   [Full Text] [Related]  

  • 20. Positive results with autologous transplant of ZFN-modified CD4 T-cells: a step toward a practical, functional cure for HIV.
    AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22023317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.